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PURPOSE. The aim of this study was to identify differentially expressed microRNAs (miRNAs)
that might play an important role in the etiology of retinal degeneration in a genetic mouse
model of retinitis pigmentosa (rd10 mice) at initial stages of the disease.
METHODS. miRNAs–mRNA interaction networks were generated for analysis of biological
pathways involved in retinal degeneration.
RESULTS. Of more than 1900 miRNAs analyzed, we selected 19 miRNAs on the basis of (1) a
significant differential expression in rd10 retinas compared with control samples and (2) an
inverse expression relationship with predicted mRNA targets involved in biological pathways
relevant to retinal biology and/or degeneration. Seven of the selected miRNAs have been
associated with retinal dystrophies, whereas, to our knowledge, nine have not been
previously linked to any disease.
CONCLUSIONS. This study contributes to our understanding of the etiology and progression of
retinal degeneration.
Keywords: retinitis pigmentosa, miRNA, rd10, network analysis, miRNA–mRNA interaction
Retinitis pigmentosa (RP) is a heterogeneous collection ofinherited retinal degeneration diseases that leads to vision
impairment and for which there is no standard treatment. It is
characterized by the progressive death of retinal photoreceptor
cells. The primary defect underlying RP affects the function of
photoreceptors and/or retinal pigment epithelium cells, where
molecular and cellular mechanisms trigger the apoptotic
degeneration of rods and in many cases cones.
Despite there being more than 350 genes and/or loci
associated with retinal dystrophies, the precise mechanisms
that link mutations in these genes with retinal degeneration are
still not well defined. In addition to many molecular pathways
involved in both survival and death of photoreceptors and RPE
cells, there is growing evidence of the role of epigenetic
mechanisms as key players in gene expression regulation,
retinal development and function, and photoreceptors surviv-
al.1,2 These include effects mediated by microRNAs (miRNAs),
small RNAs that partially inhibit the translation of a transcript or
cause mRNA degradation.3 According to the current version of
the miRBase database (www.mirbase.org), more than 2000
human miRNAs have been identified, each of which targets
several hundreds of different mRNAs, mostly due to the fact
that most target sites on the mRNA have only partial base
complementarity with their corresponding miRNA. Moreover,
individual mRNAs may contain multiple binding sites for
different miRNAs, resulting in a complex regulatory network.
Taken together, it appears that relatively few miRNAs can
regulate as many as 50% to 60% of genes in humans and other
mammals.4
Control of protein expression mediated by miRNA modula-
tion has been described as a widely used mechanism for
posttranscriptional regulation of metabolic pathways.5,6 There
is growing evidence of the involvement of miRNAs dysregula-
tion in a broad spectrum of health problems, including various
types of cancer and heart and inflammatory diseases, as well as
in hereditary diseases such as cystic fibrosis.7–15
Current molecular tools have allowed the selective modu-
lation of miRNA expression. This has led to the development of
what will become the first clinical trials based on an antisense
approach seeking to regulate miRNA function in patients with
cardiovascular conditions.16
More than 250 miRNAs have been identified in the retina,
and recent studies have shown the relevance of Dicer, a key
enzyme in miRNA biogenesis, in photoreceptor survival.2,17
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Similar to many other human conditions, retinal diseases also
involve miRNA dysregulation. Indeed, there is a growing list of
miRNAs that are known to be differentially expressed in retinal
disorders in humans and in animal models, including miR-9,
miR-34a, miR-125b, and miR-155 in macular degeneration,18,19
miR-146a and miR-195 in diabetic retinopathy,20,21 and miR-
125a and miR-17 in retinoblastoma.22,23 In addition, a group of
antiapoptotic miRNAs (miR-155, miR-146a, and miR-29b) was
found to be differentially expressed during the chronic cell
death stage in canine models of retinal degeneration.24
Furthermore, a common pattern of aberrantly expressed
miRNAs was described in four murine models of RP where
miR-1, miR-133, and miR-142 were upregulated despite
different genes (Rho and Rds) and inheritance patterns being
involved.25,26
To identify potential miRNAs associated with the etiology of
RP, we used the retinal degeneration 10 (rd10) mouse: a well-
established mouse model of autosomal recessive RP, which
carries a spontaneous point mutation in exon 13 of the b
subunit of the rod phosphodiesterase gene (Pde6b). This
mutation results in deregulation of intracellular calcium
homeostasis that leads to photoreceptor cell death via
apoptosis.27–29 Mutations in the PDE6b gene also cause RP in
humans accounting for approximately 5% of all autosomal
dominant RP cases worldwide.30,31 Therefore, rd10 mice
provide a useful and widely used model of RP that closely
resembles the human disease emulating the progression of
typical autosomal recessive RP.
In summary, we analyzed the expression pattern of miRNAs
and associated mRNAs during the early stages of retinal
degeneration. Our results provide valuable insights into the
molecular mechanisms underlying RP, including the identifica-
tion of differentially expressed miRNAs, and the association of
predicted mRNA targets in the retina of the rd10 mice. These
include both miRNAs previously reported in retinal studies,
such as miR-1a, miR-133a, miR-146a, miR-17, miR-29b, and
miR-155, and miRNAs not previously ascribed to any disease,
namely miR-6937, miR-6240, miR-3473b, and miR-6970. This
study might also help to identify potential miR-based thera-
peutic approaches.
MATERIALS AND METHODS
Ethics Statement and Animal Handling
Animal handling and experiments were conducted in accor-
dance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research and were approved by the
Animal Care and Use Committee of Donostia University
Hospital and the Clinical Research Ethics Committee of the
Basque Country, Spain. Studies were performed using age-
matched wild-type (WT) C57BL/6J mice as controls and a
congenic inbred strain of rd10 mice, both purchased from the
Jackson Laboratory (Bar Harbor, ME, USA). Animals were
maintained under a 12-hour light/12-hour dark cycle at 228C,
with controlled humidity, ranging between 45% and 55%, and
with water and food provided ad libitum at the Animal Facility
of BioDonostia Health Research Institute in San Sebastian
(Spain).
Sample Collection
Rd10 and age-matched WT mice were euthanized by cervical
dislocation following CO2 inhalation. All mice were euthanized
at the same time of day to minimize possible bias from
circadian effects on miRNA expression.
Retinal tissue from each animal was isolated and kept at 48C
within a few minutes until use. Total RNA isolation was
performed using the miRNeasy Mini Kit and RNase-Free DNase
Set (Qiagen, Woburn, MA, USA), in accordance with the
manufacturer’s protocol. RNA was stored at 808C until use.
Only those RNA samples with A260/A280 ratios greater than
1.8 were used, as determined by a Nano-Drop ND-1000
spectrophotometer (Nanodrop Technologies, Wilmigton, DE,
USA). Furthermore, sample quality was tested in each of the
different RNA expression profiling arrays described below.
Eyes were enucleated, fixed in PBS containing 4% parafor-
maldehyde, and cryoprotected in PBS containing 30% sucrose.
They were then embedded in OCT (Tissue Tek, Sakura Finetek,
Tokyo, Japan) and sectioned at 7 lm in a cryostat.
Time Course of Photoreceptor Cell Death
We used a terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL) assay to study the photore-
ceptor cell death process to select the time points for
collection of retinal samples for our miRNA/mRNA expression
studies. We analyzed retinal sections from postnatal days 13 to
22 (P13 to P22), obtained at 12-hour intervals using the
DeadEnd Fluorometric TUNEL System (Promega, Madison, WI,
USA). At least three samples were analyzed for each
experimental group and time point.
Global miRNA and mRNA Expression Profiling
A detailed global analysis of miRNA expression and its
correlation with the transcriptome was performed using the
miScript miRNA PCR array (Qiagen), GeneChip miRNA 4.0
array and GeneChip Mouse Transcriptome Array 1.0 (MTA 1.0)
(Affymetrix, Santa Clara, CA, USA), covering 100% of miRBase
v20 mouse miRNAs and 100% of the mouse transcriptome.
Three miScript miRNA PCR Arrays (Qiagen; MIMM-001Z)
were used to analyze 12 samples from pooled retinas,
corresponding to two samples per experimental group, rd10
and WT, from three time points: P13, P15, and P17. Each
sample consisted of a pool of nine retinas from six mice.
Ten GeneChip miRNA 4.0 arrays and 10 GeneChip Mouse
Transcriptome Arrays 1.0 were used to analyze 10 samples
from pooled retinas: 3 for each rd10, from P13, P15, and P17
and 1 for WT from P13. Each sample consisted of a pool of nine
retinas from six mice (Supplementary Fig. S1).
We first performed analysis of raw data from all GeneChip
arrays, including a detection step (a probe set being detected
above background with an associated P value) resulting in an
absence/presence call and a quantile normalization step using
the Expression Console Software v 1.4.1 (Affymetrix). In a
subsequent filtering step, all nonmouse probe sets and those
that were not detected (values below the background signal) in
any of the arrays were removed to ensure that we worked with
miRNAs and mRNAs actually expressed in mouse retina.
For identification of differentially expressed (DE) miRNAs
and mRNAs, we used as reference rd10 and WT mice at P13 (in
GeneChip arrays), 3 days prior to the onset of apoptosis.
Adjusted P < 0.05 was considered statistically significant, and
fold-change cutoffs of 61.5 and 61.3 were used for miRNAs
and mRNAs, respectively. Further criteria used included the
exclusion of miRNAs with values close to the background
signal and triplicates with a high SD.
We then filtered the list of DE miRNAs based on fold-change
values and on initial prediction studies of their putative target
mRNAs (i.e., whether the corresponding genes were poten-
tially relevant to retinal pathways in health and disease, such as
genes known to be involved in apoptosis, inflammation, or
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normal retinal function or previously reported to be related to
RP).
Candidate miRNAs were further classified into two groups
based on their expression dynamics (i.e., whether altered
expression occurred prior to or just after the onset of
photoreceptor apoptosis) as follows: (1) group A, miRNAs
with a significant up/downregulation at P13 and P15 compared
with age-matched WT (P13 and P15) and rd10 at P13; and (2)
group B, miRNAs with a differential expression at P17
compared with age-matched WT (P17) and with rd10 at P13:
with no differential expression found at previous stages. In line
with these criteria, we considered group A to contain the
miRNAs that were most likely to be involved in the disease
etiology and group B the miRNAs that were more likely to be
involved in compensatory mechanisms and/or in disease
progression.
miRNA–mRNA Interaction Network Analysis and
Gene Ontology and Pathway Enrichment Analysis
In silico prediction of mRNA targets for DE miRNAs was
obtained using the miRWalk 2.0 database (available in the
public domain, http://zmf.umm.uni-heidelberg.de/apps/zmf/
mirwalk2/),32 which is able to predict targets for miRNAs using
the algorithms of several databases including miRWalk 2.0
itself, miRanda,33,34 TargetScan,35 and RNA22,36 among others.
Using Cytoscape v3.0.0 open access software,37 we construct-
ed miRNA–mRNA interaction networks with both DE miRNAs
and their target mRNAs as predicted by miRWalk 2.0. Only
genes predicted by at least two algorithms were considered for
further analysis.
To identify inverse expression relationships among miRNAs
and mRNAs, we filtered these networks by incorporating the
data from our mouse transcriptome arrays, selecting mRNAs
with enriched expression in the retina (signal values above
background) and mRNAs with an opposite fold change to that
of their predicted regulator miRNAs. We generated three
interaction networks, namely group A miRNAs versus DE
mRNAs at P15 and at P17 and group B miRNAs versus DE
mRNAs at P17.
The differentially expressed putative target genes whose
transcript levels were inversely expressed relative to the
relevant DE miRNAs (inversely expressed genes) underwent
analysis of gene ontology. For this purpose, we used Cyto-
Scape’s ClueGO app (version 2.2.3) and analysis of biological
pathways38 based on the Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID, available in the public
domain, http://david.abcc.ncifcrf.gov/) and WikiPathways
(available in the public domain, www.wikipathways.org) to
identify biological processes affected by miRNA dysregulation.
Validation of miRNA and mRNA Expression by
Quantitative PCR
Expression levels of DE miRNAs and inversely expressed
mRNAs were analyzed for validation using a second technique,
quantitative PCR (RT-qPCR). Validation was performed in the
same samples as those studied in array analysis (i.e., three
samples for each rd10 and WT mouse at three different time
points [P13, P15, and P17]). RT-qPCR was conducted using
miScript Primer Assays and the miScript SYBR Green PCR Kit
(Qiagen, Hilden, Germany) for miRNA expression and the
SYBR Green PCR Master Mix (Applied Biosystems, Foster City,
CA, USA) for mRNA expression, according to the manufactur-
er’s protocol. Each biological sample was amplified in
triplicate. Threshold cycle values for miRNA expression were
normalized to the mean expression values of miR-26a and miR-
191-5p, which showed lowest variability of expression levels
among all samples analyzed. For normalizing mRNA expres-
sion, we used the mean values of Gapdh, Tubb5, and b-Act
genes for mRNA expression, which showed strong correlation
between themselves in their levels of expression across all
samples (r2 ¼ 0.905 and P < 0.001).
RESULTS
Using the rd10 mouse model of RP, we conducted a detailed
global study of the expression of more than 1900 miRNAs and
the correlation of the levels of expression with the whole
transcriptome to investigate possible differences in miRNA and
mRNA expression profile between rd10 and WT mice retinas.
This allowed us to identify a set of differentially expressed
miRNAs and to analyze their possible role in the biological
pathways involved in retinal degeneration through their
predicted target genes.
TUNEL Analysis
We carried out a detailed analysis of photoreceptor cell death
dynamics in retinal sections obtained from mice ranging from
P13 to P22 at 12-hour intervals to select the time points of
interest for the miRNA–mRNA expression studies (Fig. 1). No
TUNEL signal indicating apoptosis was detected prior to P16
(Figs. 1A–1F). A signal appeared on P16 in the central retina,
mainly restricted to the outer nuclear layer (ONL) and
progressed toward the peripheral retina, similar to what has
been observed in previous studies.28,29 Based on our results,
we selected retinal samples at three key time points for miRNA
and mRNA expression profiling studies: prior to the onset of
apoptosis at P13 and P15 and just after the onset of apoptosis
at P17.
miRNA and mRNA Expression Profiling
Based on the photoreceptor cell death dynamics, we
analyzed the overall expression of miRNAs and mRNAs
immediately prior to and after the onset of apoptosis, at
P15, and at P17, when virtually all photoreceptors were still
present. We also analyzed rd10 retinas at P13 to profile
miRNA expression at an early stage, 3 days prior the onset of
apoptosis. We considered that any possible alteration in the
miRNA profile that could be happening in the rd10 mouse at
this early stage is less likely to be influenced, if at all, by the
apoptotic processes at this time.
The GeneChip miRNA 4.0 arrays revealed a large number of
significantly differentially expressed (DE) miRNAs between the
two strains with a greater than 61.5-fold change (P < 0.05;
Supplementary Table S1). Of more than 1900 miRNAs
explored, 152 miRNAs were differentially expressed in the
retina of rd10 mice with respect to control samples, and from
this subset, we compiled a list of 19 candidate miRNAs for qRT-
PCR validation analysis based on fold-change values and on
preliminary prediction studies of their target mRNAs. In
addition, miScript miRNA PCR arrays revealed a total of 18
DE miRNAs, this list being reduced to 6 candidate miRNAs by
applying the same filtering criteria as for the GeneChip arrays
(Supplementary Table S2). Therefore, our candidate miRNA list
increased to 25 miRNAs, of which 19 were upregulated and 6
were downregulated.
Validation of candidate miRNAs was performed by qRT-PCR.
Of 25 miRNAs tested, 19 miRNAs were validated. Data were
presented as fold change over controls (Table 1). Most of the
validated miRNAs were upregulated (17 of 19 miRNAs), and
only two of six downregulated miRNAs were validated by qRT-
PCR. Among validated miRNAs, the most highly upregulated
miRNA–mRNA Network Interaction in Retinitis Pigmentosa IOVS j May 2018 j Vol. 59 j No. 6 j 2383
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937022/ on 11/19/2018
were miR-6240 and miR-6970 (22-fold and 21-fold at P17,
respectively), whereas miR-20b-5p and miR-19b-3p were the
only miRNAs that were downregulated (1.76-fold and 1.73-
fold at P17, respectively).
The expression of three group B miRNAs, miR-155-5p,
miR-142a-5p, and miR-146a-5p, were analyzed over a longer
time frame, including measurements at P19 and P22. We
selected these miRNAs based on the magnitude of the
differential expression and/or the relevance of their predict-
ed target genes in the disease. Expression of this group of
miRNAs continued to increase at P19, reaching a plateau by
P22, with expression values similar to those observed at P19
for miRs 155-5p and 146a-5p, and a marked drop in FC
values from 12 to 3 for miR-142a-5p at P22 (Fig. 2). This
pattern in expression levels from P19 might be indicating an
exhaustion of compensatory mechanisms due to irreversible
photoreceptor (PR) loss. Following the same selection
criteria as that applied for group B, we selected four
miRNAs to analyze over a longer time frame, namely, up to
22 days: miR-6240, miR-6937-5p, miR-3473b, and miR-7035-
5p. The miRNA expression levels were still elevated at P19,
decreasing to expression levels comparable to WT retinas by
P22 (Fig. 2).
Target Gene Analysis and miRNA–mRNA Networks
We identified an average of 900 target genes for each miRNA.
Information from these target gene analyses was combined
with data from miRNA expression profiling arrays to construct
miRNA–mRNA regulatory networks using CytoScape open
access software (Fig. 3; Supplementary Fig. S1). Then, we
filtered these networks using data from our mouse tran-
scriptome arrays. This approach allowed us to identify genes
with levels of expression that were inversely correlated with
those of our candidate miRNAs, which may play important
roles in retinal degeneration. The 554 inversely expressed
genes identified were analyzed using DAVID and WikiPathways
open access databases to acquire knowledge about their
biological relevance and to identify new actors and their
involvement in the retinal degeneration process.
FIGURE 1. Photoreceptor cell death in rd10 mouse retina. (A, B) PR cell death (green nuclei) starts abruptly at P16 in the central retina, with no
apoptotic nuclei detected neither at P13.5 (data not shown) nor at P15.5. (C–G) Cell death progresses toward the periphery. (H) Schematic
representation of the PR cell death process. Preapoptotic nuclei are represented by blue circles and apoptotic nuclei are represented by green
circles. Red squares represent the retinal areas where images were captured. Cell nuclei (blue) are labeled with 40,6-diamino-2-fenilindol (DAPI),
GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; ON, optic nerve.
TABLE 1. List of Differentially Expressed miRNAs Validated by RT-qPCR
miRNA
Fold-Change
P15 P17 P19 P22
Group A
miR-6240 2.72 22.21 39.52 5.03
miR-6970-5p 2.32 21.83 — —
miR-3473b 2.75 17.41 54.44 4.42
miR-6937-5p 2.05 10.22 34.2 6.48
miR-7115-5p 2.16 5.02 — —
miR-7035-5p 2.81 4.37 10.58 1.81
miR-7081-5p 1.94 2.88 — —
miR-20b-5p* 1.76 1.58 — —
Group B
miR-142a-5p 1.09 4.71 12.67 3.1
miR-7221-3p 1.02 4.22 — —
miR-146a-5p 1.19 3.32 5.31 4.96
miR-1a-3p* 1.36 2.83 — —
miR-155-5p 1.18 2.76 4.74 3.71
miR-7036b-3p 1.21 2.63 — —
miR-762 1.17 2.41 — —
miR-133a-3p 1.17 2.22 — —
miR-29b-3p 1.79 2.03 — —
miR-17-5p 1.31 2.01 — —
miR-19b-3p 1.31 1.73 — —
Not validated
miR-7002-5p 1.08 (4.95) 1.12 (33.58) — —
miR-346-3p 1.2 (1.26) 1.1 (3.95) — —
miR-216a-5p 1.04 (1.08) 1.08 (2.17) — —
miR-3074-1-3p 1.32 (1.15) 1.05 (2.77) — —
miR-15b-5p 1.2 (1.36) 1.59 (2.01) — —
miR-106a-5p 1 (1.50) 1.17 (2.22) — —
All fold-change values are calculated with respect to WT samples
from the same postnatal day, except those indicated by an asterisk in
which it was calculated with respect to rd10 samples at P13. The
miRNAs are grouped into two groups (A and B) depending on whether
they underwent differential expression prior to or after apoptotic onset
(Materials and Methods). Note that in the list of not validated miRNAs,
the values in parentheses correspond to the calculated fold-change
using data from the miRNA 4.0 arrays.
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Gene Ontology and Pathway Analysis
Target genes with an expression that was inversely correlated
with that of the differentially expressed miRNAs subsequently
underwent analysis of genetic ontology (GO) and biological
pathways to improve our understanding of the mechanisms by
which the candidate miRNAs might affect the rd10 mice
phenotype. For this, we used DAVID and WikiPathways web
services and CytoScape’s ClueGO application. Ontology and
biological pathway analysis revealed that a large number of
inversely expressed targets are encoding components involved
in biological functions likely to be involved in the pathogenesis
of retinal degeneration, in compensatory mechanisms intended
to prevent further retinal damage or in genes that are essential
for retinal survival (Table 2). Considering these findings, we
selected genes related to the pathways involved in apoptosis,
inflammatory response, cytokine and chemokine activation,
calcium signaling, visual perception, and visual phototransduc-
tion, among others, for qRT-PCR validation. In addition, we
selected inversely expressed genes with high fold-change
values, even if they had no clear involvement in retinal
degeneration.
For target genes of the miRNAs that we classified into group
A (i.e., differentially expressed prior to the onset of apoptosis),
we mainly focused on pathways potentially involved in
photoreceptor cell death such as apoptosis or inflammation,
whereas for target genes of the miRNAs that we classified into
the group B (i.e., differentially expressed just after the onset of
apoptosis), we mainly focused on genes involved in pathways
likely to be involved in photoreceptor survival. In addition to
this, we also detected differentially expressed genes directly
ascribed to retinal diseases such as Klhl23 or Nr2e3 involved in
cone-rod dystrophies or RP, respectively. In total, we selected
49 genes for qRT-PCR validation.
Expression levels of these 49 genes, 45 downregulated and
4 upregulated, were analyzed by qRT-PCR for validation.
Downregulation of 36 (80%) and upregulation of 3 (75%) of
the selected genes was confirmed, summing to a total of 42
genes that showed differences in expression between rd10 and
WT retinal samples. Table 2 summarizes information about the
fold regulation of the candidate miRNAs, their inversely
expressed target genes and their associated signaling pathways
that might be involved in the retinal disease.
Finally, some of these genes have predicted interactions
with more than one of the candidate miRNAs. For instance,
Pde6g, which encodes the c inhibitory subunit of the rod-
specific phosphodiesterase 6, a key component of the photo-
transduction cascade, is a target for miR-3473b, miR-7035-5p,
and miR-762. Another example is Peli3, a negative regulator of
apoptosis, which is a predicted target for miR-6937-5p and
miR-7115-5p.
DISCUSSION
In this work, we contributed to expanding our knowledge
about the molecular mechanisms underlying RP. We identified
a total of 19 candidate miRNAs that may play a fundamental
role in the physiopathology and/or in the progression of the
disease. GO and pathways enrichment analysis showed that
some of the genes targeted by these miRNAs, which also
showed differential expression between rd10 and WT mice,
FIGURE 2. miRNAs expression levels in rd10 mouse retina. Differential miRNA expression at postnatal days 13, 15, 17, 19, and 22 are measured as
the fold-changes compared with age-matched WT samples (left) and rd10 P13 samples (right). (A, B) Group A miRNAs. (C, D) Group B miRNAs. See
Materials and Methods for a description of groups A and B.
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are involved in biological pathways with potential roles in
retinal degeneration or survival.
Given the established role played by miRNAs in retinal
development and survival,1,2 as well as in a growing number of
distinct diseases,7–10,12,14,15,19,22,39,40 we hypothesized that
alterations in miRNA expression might contribute to the
molecular mechanisms involved in the physiopathology of
RP. To provide experimental evidence to support the possible
FIGURE 3. miRNA–mRNA interaction networks. A selection of representative differentially expressed miRNAs (red squares) and their predicted
target genes with an inverse expression relationship (green circles). (A) miRNA–mRNA network of differentially expressed miRNAs prior to the
onset of apoptosis (group A) and (B) just after the onset of apoptosis (group B). Arrows indicate direct interactions between an miRNA and its target
genes. Changes in the shade of green of mRNA nodes reflect differences in fold-change, starting from 1.3-fold (light green) to up to4.33-fold in
group A and 7.65-fold in group B (dark green).
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association between miRNA expression and retinal degenera-
tion, miRNA expression profile in retinas from the rd10 RP
mouse model27–29 and C57BL/6J wild-type mice were com-
pared by microarray and RT-qPCR analysis in the early stages of
retinal degeneration. To gain further insight into the possible
relationship between miRNA alteration and gene expression
regulation with implications in retinal degeneration, we also
performed transcriptome expression profiling of the same
samples as used for miRNA expression analysis.
We considered it likely that miRNAs down- or upregulated
at a stage just prior to the onset of apoptosis might be
associated with PR cell death mechanisms. Following the same
rationale, we considered that miRNAs that are deregulated at
latter stages might play relevant roles in compensatory
mechanisms attempting to counteract PR death. Therefore,
one of the key methodologic aspects of our study was to
establish the time points for the miRNA–mRNA expression
profiling analysis having first ascertained the exact time of
onset of photoreceptor degeneration in our rd10 mouse
model.
According to previous studies, the onset of PR apoptosis in
the rd10 mouse was reported to take place between the
second and third postnatal weeks.27–29,41 The onset of PR
death is dependent on light conditions, with slight differences
reported among different laboratories, depending on the
intensity and duration of animals’ exposure to light.42 To
accurately establish the onset of the death of these cells, retinal
samples were obtained every 12 hours between P13 and P22
and analyzed using TUNEL assay. We determined that apoptosis
starts in the central retina between P15.5 and P16, with PR cell
death then progressing toward the periphery (Figs. 1D–1F), in
accordance with previous reports.28,29,41
One of the pathways that we focused on was inflammatory
response; previous studies have evidenced that sustained
chronic inflammatory process may contribute to the etiology
of RP in rd10 mice and in other animal models of retinal
degeneration.43–46 Furthermore, these studies support the
notion that miRNAs are rapidly upregulated in response to
inflammatory signals and may either stimulate the magnitude
and duration of inflammation or silence it.47 Example of some
of the genes related with inflammatory or immune response
included Sema7a, Pan2, Pla2r1, Thbs1, or Trim36. Taking into
account that deregulation calcium homeostasis plays a key role
in retinal degeneration in rd10 mice, pathways involved the
regulation, signaling, and/or exocytosis of this cation were also
selected for validation, such as those related with Doc2b or
Pde6g genes. In addition, we selected genes involved in
physiologic processes or in the normal function of retinal cells,
such as intraciliary transport (Lac5), phototransduction signal
(Rgr), or retinol metabolism (Ttr).
Interestingly, among the inversely expressed genes, there
were genes previously linked to retinal disorders. For instance
Klhl23 and Nr2e3, which are predicted targets of miR-6240,
are linked with cone-rod dystrophy48 or RP,49 and Rrg, a
predicted target of miR-3473b is associated with chorioretinal
atrophy.50
With respect to most of the putative target genes, they
showed a modest differential expression, in comparison with
that found in the expression of their associated miRNA. That is,
despite some miRNAs showing fold-change values greater than
5 or even 10, their predicted target genes showed a significant,
although rather modest changes in their expression levels of
about 1.5- to 2-fold, with the exception of Serpina3n, Xaf1,
and Osmr, with fold-change values of 113, 7, and 7,
respectively (Table 2). This difference in the magnitude of
the expression levels of miRNAs and their target genes could
be a consequence of the complex regulatory network in which
a relatively few miRNAs can regulate as many as 50% to 60% of
genes in humans and other mammals. Therefore, convergence
of miRNA action on hundreds of genes implies that single
miRNAs may have limited effect on the expression of their
mRNA targets.4 Moreover, it should also be considered that
some of the candidate miRNAs might be inhibiting protein
translation rather than degrading mRNA. In such cases, mRNA
levels would not be affected. Notwithstanding the fact that
they showed significant but relatively small differences in
expression, they are of potential interest in the context of
molecular mechanisms underlying RP.
It is also remarkable that in most of genes with an inverse
expression to that of group A miRNAs, that is, miRNAs
deregulated at P15, showed significantly differential expression
at P17, but not at P15. This delay might be related to the time
that miRNAs require to exert their silencing effect on their
mRNA targets. To the best of our knowledge, this is the first
study that has described a time-delayed interaction between
differentially expressed miRNAs and their predicted mRNA
targets. This was possible through transcriptome analysis of
retina samples at both P15 and P17, which allowed us to
identify reverse expression relationships between DE miRNAs
and their target mRNAs in a time resolved manner. In this
regard, we considered that a 2-day lag time would allow a given
miRNA to exert its inhibitory effect over its target mRNAs. Had
we only studied miRNA and mRNA profiles at the same time
points, the identification of this interaction would have been
missed in most cases.
There are previous reports of the involvement of miRNAs in
retinal development, function, and photoreceptors survival1,2
and also the involvement of different miRNAs in the
pathogenesis of various diseases of the retina including miR-
9, miR-34a, miR-125b, and miR-155 in macular degenera-
tion,17,18 miR-146a and miR-195 in diabetic retinopathy,19,20
and miR-125a and miR-17 in retinoblastoma.21,22
Interestingly, some of the differentially expressed miRNAs
we detected just after the onset of apoptosis are common to
some of these retina-related miRNAs, including miR-146a, miR-
155, miR-29b, and miR-17 (Table 1), as described below.
MiR-17 is a member of the miR-17-92 cluster that has been
implicated in inflammatory diseases,51 Burkitt lymphoma,52
and retinoblastoma.53 Some evidence suggests that this cluster
regulates a broad spectrum of biological processes of T-cell
immunity including a negative expression relationship be-
tween miR-17 and the synthesis of Sirp-a gene that effectively
regulate macrophage inflammatory responses.54
Among the retina-related miRNAs described above, we only
found miR-17 and miR-29b to be inversely expressed with
genes involved in pathways with a putative involvement in
retinal degeneration. Examples of this are Mtfp1 and Mllt11,
both target genes for miR-17, and involved in positive
regulation of apoptotic process.55,56 With regard to miR-29b,
we detected downregulation of Pla2r1, Pan2, and Duxbl2,
genes targeted by this miR that have been implicated in
inflammatory and immune responses.57 Hence, increased
expression of miR-17 and miR-29b could be part of survival
mechanisms initiated to slow down the PR cell death process
via the modulation of these genes.
As far as RP is concerned, Loscher et al. reported
upregulation of miR-1a, miR-133a, and miR-142a in four
different mouse models of RP linked to genes involved in both
autosomal dominant and autosomal recessive forms of the
disease, rhodopsin and rds/peripherin, respectively. Our
results in rd10 mice are consistent with their findings.25,26
These results reinforce the hypothesis that there are common-
alities in the miRNAs expression pattern in different types of
RP regardless of the nature of their genetic cause, which could
open the way to common therapeutic strategies applicable to
different types of RP.
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PathwayID Regulation P15 P17
miR-6240  Klhl23 1.09 1.85 Cone-rod dystrophy/vitamin B6 metabolism
Nr2e3 1.01 2.05 RP/regulation of transcription
Nxnl2 1.15 1.72 Visual perception
Rs1 1.29 2.19 Retina layer formation/adaptation of rhodopsin mediated signaling/retinoschisis
miR-6937-5p  Doc2b 1.09 2.11 Positive regulation of calcium ion-dependent endocytosis of neurotransmitter
Lca5 1.43 1.59 Leber congenital amaurosis/intraciliary transport/photoreceptor maintenance
Peli3 1.01 1.46 Negative regulation of extrinsic apoptotic signaling pathway
miR-6970-5p  Eif2s3y 1.29 1.89 GTP catabolic process
miR-7035-5p  Cngb1 1.05 1.52 Phototransduction
Sema7a 1.03 1.57 Inflammatory response
Vopp1 1.04 1.81 Signal transduction/transcription, DNA-templated
Nnat 1.08 1.36 Neuron differentiation/maintenance of structure of nervous system
Pde6g 2.02 3.86 RP/visual perception
miR-7115-5p  Peli3 1.01 1.46 Negative regulation of extrinsic apoptotic signaling pathway
Nnat 1.08 1.36 Neuron differentiation/maintenance of structure of nervous system
miR-7081-5p  Prdm1 1.21 1.49 Eye photoreceptor cell development
Nr2e3 1.01 2.05 RP/regulation of transcription
Psd2 1.25 1.33 Positive regulation of GTPase activity/neuron differentiation
miR-3473b  Cryaa 1.01 1.61 Negative regulation of apoptotic process/camera-type eye development
Pde6g 2.02 3.86 Retinitis pigmentosa/visual perception
E2f3 1.24 1.63 Regulation of transcription, DNA-templated
Rgr 1.19 2.56 Visual perception/phototransduction
Trafd1 1.25 1.72 Negative regulation of innate immune response
miR-20b-5p*  Serpina3n 3.98 112.8 Inflammatory response
Xaf1 1.38 6.91 Apoptotic process
Osmr 1.82 7.43 Response to cytokine
miR-29b-3p  Duxbl2 1.17 1.74 Regulation of T-cell differentiation
Pan2 1.38 1.31 Inflammatory response
Pla2r1 1.28 1.67 Inflammatory response
miR-133a-3p  Rdh12 1.02 1.59 Visual perception
miR-146a-5p  Tdrd7 1.23 1.83 Associated with cataract
miR-762  Rgr 1.19 2.56 Visual perception/phototransduction
Pde6g 2.02 3.86 RP/visual perception
Trafd1 1.25 1.72 Negative regulation of innate immune response
Nnat 1.08 1.36 Neuron differentiation/maintenance of structure of nervous system
E2f3 1.24 1.63 Regulation of transcription, DNA-templated
Otud7b 1.01 1.58 Immune system process
miR-7036b-3p  Eif2s3y 1.29 1.89 GTP catabolic process
Crx 1.14 1.48 Visual perception/retina development in camera-type eye
Ptn 1.24 1.48 Negative regulation of neuron apoptosis
Ttr 1.31 1.94 Retinol metabolic process
miR-7221-3p  Rdh8 1.07 1.37 Visual perception/retinol metabolic process/AMD
Pan2 1.38 1.31 Inflammatory response
Rgr 1.19 2.56 Visual perception/phototransduction
Rs1 1.29 2.19 Retina layer formation/adaptation of rhodopsin mediated signaling/retinoschisis
Lca5 1.43 1.59 Intraciliary transport/photoreceptor maintenance
Vopp1 1.04 1.81 Signal transduction/transcription, DNA-templated
Fabp7 1.46 1.93 Neurogenesis/associated with optic nerve glioma
miR-142a-5p  Trp53bp2 1.27 1.59 Apoptotic process
Trim36 1.26 1.96 Immune system/ubiquitination of antigen and Proteasome degradation
Thbs1 1.21 1.57 Inflammatory response/positive regulation of macrophage chemotaxis
Rraga 1.07 1.39 Apoptotic process/cell death
miR-17-5p  Dpysl5 1.29 1.35 Nervous system development
Mtfp1 1.18 1.43 Positive regulation of apoptotic process
Mllt11 1.43 1.33 Positive regulation of apoptotic process
miR-155-5p  Arhgap18 1.25 1.32 Signal transduction/positive regulation of GTPase activity
Zfp322a 1.16 1.61 Regulation of transcription, DNA-templated
Only those target mRNAs with inverse expression were selected. Biological pathways associated with selected mRNAs likely involved in the
degeneration of the retina are shown on the right. All fold-change values are calculated with respect to age-matched WT except those indicated by
an asterisk, where fold-change were calculated with respect to retinas from rd10 mice at P13.
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However, the role that upregulation of either miR-1 alone or
the miR-1/133a cluster might be playing in the apoptotic
process is not exempt from controversy. There are data
suggestive of both anti- and proapoptotic effects on myocar-
diocytes under ischemic conditions, by targeting of the
proapoptotic genes Casp9 and Bcl258,59 and prosurvival genes
including Pkce; Hsp60, and Igf1,60,61 respectively.
In any case, differential expression of miR-1a, miR-133a, and
miR-142 in our study, as well as in the work of Loscher et al., is
observed after the onset of apoptosis. This might be reflecting
an activation of compensatory mechanisms in an attempt to
prevent photoreceptor cell death in the mutant retina. In
support of this, selective ablation of Mu¨ller cells resulted in
photoreceptor death, and an altered expression of miR-1a, miR-
133a, and miR-142.39 Hence, the observed increase in the
expression of miR-142a and the miR-1a/133a cluster might be a
direct consequence of the cell death process and a common
feature in diseases that cause inflammation and apoptosis.
Among genes expressed inversely to miR-142a, we found
genes involved in apoptosis (Trp53bp2 and Rraga), and in
inflammatory responses (Thbs1 and Trim36). Trp53bp2 acts as
a positive regulator of the execution phase of apoptosis by
encoding a member of the ASPP family (apoptosis-stimulating
protein of p53) and Rraga plays a direct role in a Tnfa signaling
pathway leading to induction of cell death.62 On the other
hand, Thbs1 is involved in inflammation through the activation
of phospholipase C enzymes, which results in intracellular
calcium levels rising and the activation of protein kinase C
(PKC) in platelets,63 and Trim36 is part of the superfamily of
tripartite motif-containing (TRIM) proteins, which are induced
by type I and II interferons and are crucial for induction of
effective immunity.64 The fact that the expression of these
genes decreased in the early stages of retinal degeneration may
be indicating an attempt to counteract the cell death process
by increasing the expression of miR-142a.
Differential expression of miR-7036b-3p, miR-7221-3p, and
miR-762 was found at P17 compared with WT samples with no
differential expression detected at P15. Among them, only one
has previously been linked to disease, namely miR-762, which
has been linked to vascular smooth muscle cell calcification65
and breast cancer.66 Notably, in the current study, we detected
an inverse expression relationship between miR-762 and the
Pde6g gene. As already discussed, Pde6g is a key player in the
phototransduction cascade. Hence, increased levels of miR-762
might be contributing to exacerbate the death of rod cells in
this mouse model with mutations in the Pde6b subunit by
silencing the expression of the inhibitory c subunit Pde6g of
the PDE6 protein complex.
In addition, we found an inverse expression relationship of
miR-762 with Rgr, Trafd1, Nnat, E2f3, and Otud7b mRNA,
whose downregulation might be involved in the physiopathol-
ogy of retinal degeneration, these genes having roles in
relevant retinal processes such as phototransduction, negative
regulation of the innate immune response, maintenance of
nervous system structure, and regulation of transcription and
immune system processes, respectively, according to GO and
pathway enrichment analysis.
Interestingly, we found decreased expression of putative
target genes for miR-7036b-3p and miR-7221-3p that might be
involved in the development of retinal dystrophy rather than in
compensatory mechanisms. Specifically, the target genes for
miR-7036b include Ptn, a negative regulator of neuron
apoptosis, and Crx, a causal gene of RP and other inherited
retinal dystrophies. Further, one predicted target gene for
7221-3p is Rdh8, which encodes a retinol dehydrogenase that
catalyzes the reduction of all-trans-retinal to all-trans-retinol,
the first reaction step of the rhodopsin regeneration pathway,
and its deficiency has been linked to AMD.67
Nevertheless, although it is possible that the above-
mentioned genes, with significantly reduced levels of mRNA
expression, are involved in the retinal degeneration in the rd10
mice, differential downregulation of miR-762, miR-7036b-3p,
and miR-7221-3p takes place after the onset of PR apoptosis.
Therefore, further studies are required to discern whether
these three miRNAs are contributing to the physiopathology or
to the progression of the retinal dystrophy.
Group B miRNAs, which have been previously associated
with retinal diseases, were up- or downregulated after the
onset of retinal degeneration. This might be indicating an
involvement of these miRNAs in compensatory mechanisms
against PR cells death or a deregulation resulting from PR cell
death itself, and it is considered less likely that they contribute
to disease onset.
In contrast, group A miRNAs showed differential expression
at P15, prior to the onset of apoptosis. Therefore, this group of
miRNAs may play important roles in the etiology of retinal
dystrophy. Strikingly, to the best of our knowledge, none of the
miRNAs included in group A have been previously linked to
any retinal disease.
Group A is composed of seven miRNAs: miR-6937-5p, miR-
6240, miR-3473b, miR-6970-5p, miR-7035-5p, miR-7081-5p,
and miR-7115-5p. Notably, overexpression of all these miRNAs
had increased by P17. For instance, miR-6937-5p showed a 2-
fold upregulation at P15 and a 10-fold increase at P17.
Because most of the miRNAs we include in group A have
only been described in recent years, there is little information
regarding their possible involvement in different biological
pathways. To the best of our knowledge, these miRNAs have
not been ascribed to any disease. The expression of miR-6240-
5p was more than 22-fold higher in rd10 retinas, this being the
miRNA that showed the greatest upregulation. Among the
target genes for miR-6240-5p, we found two genes associated
with RP, Klhl23 and Nr2e3, and one with retinoschisis, Rs1.
Another noteworthy target for miR-6240 was Nxnl2, which has
been suggested to be involved in the maintenance of both the
function and the viability of sensory neurons, including
photoreceptors.68,69
The second most upregulated miRNA was miR-6970-5p
(Table 1). Inverse expression studies revealed Eif2s3y, One-
cut1, and Tspan6 genes to be negatively expressed with this
miRNA. Eif2s3y participates in the GTP catabolic process70;
Onecut1 in transcription and cell cycle regulation71; and
Tspan6 mediates immune signaling in a ubiquitination-
dependent manner.72
miR-6937-5p showed a significant 10-fold increase at P17.
Its predicted targets, Doc2b, Lca5, and Peli3, were observed to
be downregulated in our experiments. Doc2b is expressed
ubiquitously and is suggested to be involved in calcium-
dependent intracellular vesicle trafficking in various types of
cells.73,74 Diseases associated with the Lca5 gene include Leber
congenital amaurosis and severe early-childhood-onset retinal
dystrophy.75,76 This gene has functions in photoreceptor cell
maintenance and in intraciliary protein transport as part of the
centriole.77 With regard to Peli3, this gene acts as a negative
regulator of the extrinsic apoptotic signaling pathway, and its
suppression leads to enhanced formation of the death-induced
signaling complex in response to TNF.78
Two interesting putative target genes for miR-3473b that we
found to be downregulated were Rgr and Pde6g,79–81 both
involved in the phototransduction signaling cascade: Rgr as
part of the G-protein–coupled receptor signaling pathway and
Pde6g encoding the gamma subunit of cyclic GMP-phospho-
diesterase. Pde6g expression is restricted to PR, whereas Rgr is
expressed in PR, RPE, and Mu¨ller cells.
Taking into account all the aforementioned findings
regarding group A miRNAs, including the observed differential
miRNA–mRNA Network Interaction in Retinitis Pigmentosa IOVS j May 2018 j Vol. 59 j No. 6 j 2389
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937022/ on 11/19/2018
expression prior to the onset of apoptosis, the relevant role of
their target genes for the retina in health and disease, and the
sustained increased expression until at least P19, our data
support the view that it is likely that this group of miRNAs
plays an important role in the etiology of retinal dystrophy.
The observed downregulation/suppression of genes
involved in apoptosis inhibition and inflammation regulation
is in good agreement with the apoptotic death of PR cells
and inflammatory processes observed in rd10 retinas,
emphasizing the role that differentially expressed prior to
the onset of apoptosis miRNAs might be playing in the
retinal etiology.
Although it was initially proposed that miRNAs act mainly at
the protein translation level, it is now widely accepted that
both mRNA degradation and translation repression occur.
However, despite great progress in elucidating the mechanism
of miRNA-mediated mRNA targeting has been made, the extent
and frequency of these two mechanisms has not yet been
determined.82,83 In this regard, one of the limitations of our
study is that it is focused only on the analysis of mRNA
expression level.
Another limitation has to do with the predictive nature of
our study. Despite many sequence-based target computation-
al prediction algorithms having been developed and widely
used to predict miRNA targets, their use implies inherent
error in target predictions.84 These computational tools rely
not only on the sequence complementary, but on thermody-
namics, energy potentials, accessibility of target sites, and
conservation, essentially scanning the entire transcriptome to
predict a set of targets for each miRNA.85 However, this has
the limitation of not considering that the relationship
between miRNA and target genes is dynamic. This means
that under different conditions, the same miRNA could have
different sets of targets, and therefore different functions,
when expressed in different cell types. Thus, these methods
produce many false positives, even if the target information is
accurate.84 To control false positives, a strict cutoff value is
typically established; however, in this case, these methods
tend to reject many true target relationships, that is, false
negatives. Therefore, in this target prediction study, it is
necessary to bear in mind that there is an inherent error that
could condition our posterior results and that the inverse
expression of the target mRNA of a particular miRNA is not at
all proof of miRNA–mRNA regulation. Thus, miRNA–mRNA
target pairs should be further validated in biological
experiments, and therefore what our study is providing are
strong candidates, which need further experimental valida-
tion.
CONCLUSIONS
In the present work, we identified 19 DE miRNAs and 39
inversely expressed target mRNAs that may be key players
during retinal degeneration, considering the reported involve-
ment of these DE miRNAs and mRNAs in basic retinal
processes such as apoptosis and inflammation regulation,
which take place in degenerating rd10 retinas.
Among the miRNAs identified, seven have previously been
reported in retinal studies, whereas nine have not previously
been ascribed to any diseases.
As far as we are aware of, this is the first study describing a
time-delayed interaction between differentially expressed
miRNAs and their predicted mRNA targets. The identification
of disease-related miRNAs and the consequent alteration in
gene expression will contribute toward our understanding of
the etiology and evolution of retinal degeneration.
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